Nanotechnology Update: U.S. Leads in Government Spending Amidst Increased Spending Across Asia

December 29, 2015 | State of the Market Report

Governments, corporations, and private investors (venture capitalists) invested $18.1 billion in nanotechnology in 2014, increasing their spending 1.2% relative to updated 2012 figures. The U.S. contributed 33% of this amount. Corporations expanded spending by 3.5% over 2012 while private investors reduced their investments by 45%. Government spending remained consistent over this time period. The United States maintained its lead over all the other governments, with $1.67 billion of federal and state funding in 2014. U.S. corporations also lead global spending on nanotechnology R&D, investing $4.0 billion in 2014, which was approximately $1.5 billion more than the next country, Japan. The revenue from nano-enabled products has continued to grow from $850 billion in 2012 to $1.6 trillion in 2014, an increase of 90%.

Coverage Areas

  • Accelerating Materials Innovation
  • Advanced Materials
  • Nanotechnology

Table of Contents

  • Executive Summary
  • Nanotechnology Update
    Corporations continue to funnel more money into nanotechnology than governments and investors, and it pays off in increased revenues.
  • Endnotes

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978